| Identification | Back Directory | [Name]
Lenvatinib Impurity f | [CAS]
417717-21-6 | [Synonyms]
Lenvatinib Impurity f
Levatinib Impurity 11
Lenvatinib Carboxylic Acid
4-(3-chloro-4-(3-cyclopropylureido)phenoxy)-7-methoxyquinoline-6-carboxylic acid
4-[3-Chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-methoxy-6-quinolinecarboxylic acid
6-Quinolinecarboxylic acid, 4-[3-chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-methoxy- | [Molecular Formula]
C21H18ClN3O5 | [MDL Number]
MFCD32182568 | [MOL File]
417717-21-6.mol | [Molecular Weight]
427.84 |
| Hazard Information | Back Directory | [Uses]
Desamino Hydroxy Lenvatinib serves as a reagent for the synthesis of urea derivatives containing nitrogenous aromatic ring compounds that functions as angiogenesis inhibitors for treatment of diseases. It is also a derivative compound of Lenvatinib (L329400) that serves as orally active inhibitor of multiple receptor tyrosine kinases including VEGF, FGF and SCF receptors. |
|
|